good points but i dont think you have painted an entirely accurate picture,
piedmont have an earn in agreement to fund expansion , which alleviates any capital raising issues, they have an offtake for 50% which almost guarentees there is a buyer for there product so good chance mine will go ahead and comments they will not be selling spodumene at spot prices , is sort of correct they will be selling at market prices for life of mine , should be a profitable buisness
good points but i dont think you have painted an entirely...
-
- There are more pages in this discussion • 183 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
15.0¢ |
Change
-0.005(3.23%) |
Mkt cap ! $103.9M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.5¢ | 15.0¢ | $26.64K | 176.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 221595 | 15.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 16.0¢ | 56000 | 1 |
View Market Depth
| Last trade - 16.10pm 19/06/2025 (20 minute delay) ? |
| A11 (ASX) Chart |